Recce Pharmaceuticals reaches midpoint in Phase II Trial for Topical Gel R327G

By Proactive Investors / October 09, 2024 / www.youtube.com / Article Link

Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) CEO James Graham joins Proactive's Tylah Tully to discuss progress in a ...

Recent News

Largest gold producers see strong Q3/25 earnings

November 17, 2025 / www.canadianminingreport.com

Gold stocks jump on gain in metal price

November 17, 2025 / www.canadianminingreport.com

AOCE and WB boost gold targets for 2025 significantly

November 10, 2025 / www.canadianminingreport.com

Gold and silver price ETFs see major net outflows

November 04, 2025 / canadianminingreport.com

Gold stocks decline by less than metal price

November 04, 2025 / www.canadianminingreport.com

See all >